GDRX · GoodRx Holdings, Inc. · Webcasts, Transcripts & Audio
$3.36
-0.11 (-3.17%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$1.15B
Shares
341.15M
Volume · Nov 18
659.27K
Avg daily vol (3M)
1.14M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
GoodRx Holdings, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for GoodRx Holdings, Inc. (GDRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-06
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
Confident tone
GLP-1 access and demand
PharmaDirect growth
CFO transition
Revenue
$200.41M
▼ 1.3% YoY Diluted EPS
$0.02
▼ 50% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Positive tone
TrumpRx integration and incremental volume
Subscription and weight loss offering
PharmaDirect growth and scale
Revenue
$194.01M
▼ 4.4% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
Confident tone
Pharma Manufacturer Solutions / Pharma Direct
Consumer Reach and Engagement
Subscriptions
Revenue
$194.78M*
▼ 1.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript
Positive tone
Pharma Manufacturer Solutions growth
Policy environment / TrumpRx & MFN
Kroger RxSmartSaver / retail partnerships
Revenue
$196.03M
▲ 0.4% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript
Positive tone
Integrated Savings Program (ISP) headwinds
Pharma manufacturer solutions growth
Retail and prescription marketplace partnerships
Revenue
$203.07M
▲ 1.2% YoY Diluted EPS
$0.04
▲ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript
Positive tone
Prescription marketplace and pharmacy partnerships
Rite Aid bankruptcy
Pharma Manufacturer Solutions and GLP-1 opportunity
Revenue
$202.97M
▲ 2.6% YoY Diluted EPS
$0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript
Confident tone
Healthcare professional workflow tools and technology
Integrated Savings Program (ISP) and direct contracting
Pharmacy partnerships and cost-plus economics
Revenue
$198.58M*
▲ 1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript
Positive tone
Integrated Savings Program (ISP)
Pharma manufacturer solutions / brand growth
Adjusted EBITDA performance
Revenue
$195.25M
▲ 8.5% YoY Diluted EPS
$0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript
Cautious tone
Retail pharmacy store closures
Integrated Savings Program (ISP)
Pharma manufacturer solutions
Revenue
$200.61M
▲ 5.8% YoY Diluted EPS
$0.02
▼ 85.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
GoodRx Holdings, Inc. (GDRX) Q1 2024 Earnings Call Transcript
Positive tone
Integrated Savings Program (ISP)
Pharma Manufacturer Solutions
Retail direct contracting shift
Revenue
$197.88M
▲ 7.6% YoY Diluted EPS
$0.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
GoodRx Holdings, Inc. (GDRX) Q4 2023 Earnings Call Transcript
Positive tone
Retail pharmacy partnerships / hybrid model
Integrated savings program (ISP) for commercial plans
2024 financial outlook
Revenue
$196.64M*
▲ 6.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
GoodRx Holdings, Inc. (GDRX) Q3 2023 Earnings Call Transcript
Revenue
$179.96M
▼ 3.9% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
GoodRx Holdings, Inc. (GDRX) Q2 2023 Earnings Call Transcript
Revenue
$189.68M
▼ 1.1% YoY Diluted EPS
$0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
GoodRx Holdings, Inc. (GDRX) Q1 2023 Earnings Call Transcript
Revenue
$183.99M
▼ 9.5% YoY Diluted EPS
$-0.01
▼ 133.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
GoodRx Holdings, Inc. (GDRX) Q4 2022 Earnings Call Transcript
Revenue
$184.11M*
▼ 13.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript
Revenue
$187.32M
▼ 4% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
GoodRx Holdings, Inc. (GDRX) Q2 2022 Earnings Call Transcript
Revenue
$191.80M
▲ 8.6% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
GoodRx Holdings, Inc. (GDRX) Q1 2022 Earnings Call Transcript
Revenue
$203.33M
▲ 26.7% YoY Diluted EPS
$0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
GoodRx Holdings, Inc. (GDRX) Q4 2021 Earnings Call Transcript
Revenue
$213.26M*
▲ 38.9% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
GoodRx Holdings, Inc. (GDRX) Q3 2021 Earnings Call Transcript
Revenue
$195.10M
▲ 38.9% YoY Diluted EPS
$-0.04
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
GoodRx Holdings, Inc. (GDRX) Q2 2021 Earnings Call Transcript
Revenue
$176.63M
▲ 43.3% YoY Diluted EPS
$0.07
▼ 12.5% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
GoodRx Holdings, Inc. (GDRX) Q1 2021 Earnings Call Transcript
Revenue
$160.43M
▲ 20.3% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
GoodRx Holdings, Inc. (GDRX) Q4 2020 Earnings Call
Revenue
$153.54M*
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-12
GoodRx Holdings, Inc. (GDRX) Q3 2020 Earnings Call Transcript
Revenue
$140.45M
▲ 38% YoY Diluted EPS
$-0.21
▼ 520% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 webcasts
Key facts
CIK
1809519
CUSIP
38246G108
13F (30d)
191 filings
174 filers
Visit website
Investor relations